Table 1 |
|||
|
Clinicopathological characteristics of estrogen-receptor-negative breast tumors according to basal cytokeratin (CK5/14) status |
|||
|
Clinicopathological parameter |
CK5/14 negative (percentage) |
CK5/14 positive (percentage) |
p |
|
|
|||
|
All estrogen-receptor-negative tumors |
60 (63) |
35 (37) |
|
|
Axillary lymph node status |
|||
|
Negative |
23 (38) |
19 (54) |
0.14 |
|
Positive |
37 (62) |
16 (46) |
|
|
HER-2 status |
|||
|
Non-amplified |
35 (58) |
30 (86) |
0.01 |
|
Amplified |
18 (30) |
3 (9) |
|
|
Data missing |
7 (12) |
2 (6) |
|
|
p63 |
|||
|
Negative |
57 (95) |
33 (94) |
1.00 |
|
Positive |
3 (5) |
2 (6) |
|
|
p53 |
|||
|
Negative |
26 (43) |
13 (37) |
0.65 |
|
Positive |
26 (43) |
17 (49) |
|
|
Data missing |
8 (13) |
5 (14) |
|
|
Histological type |
|||
|
Invasive ductal or mixed type |
49 (82) |
28 (80) |
0.10 |
|
Invasive lobular |
5 (8) |
0 (0) |
|
|
Medullary or atypical medullary |
5 (8) |
7 (20) |
|
|
Other types |
1 (2) |
0 (0) |
|
|
|
|||
|
The p values were calculated, excluding the 'data missing' values, with Fisher's exact test except for the p value of histological type, which was calculated with the χ2 test. |
|||
|
Jumppanen et al. Breast Cancer Research 2007 9:R16 doi:10.1186/bcr1649 |
|||
